| Reference |
|---|
Angabo S, Pandi K, David K, Steinmetz O, Makkawi H, Farhat M, et al. CD47 and thrombospondin-1 contribute to immune evasion by Porphyromonas gingivalis. Proc Natl Acad Sci U S A. 2024;121:e2405534121 pubmed publisher |
Sun Y, Kronenberg N, Sethi S, Dash S, Kovalik M, Sempowski B, et al. CRB2 Depletion Induces YAP Signaling and Disrupts Mechanosensing in Podocytes. bioRxiv. 2024;: pubmed publisher |
Moniot A, Schneider C, Chardin L, Yaniz Galende E, Genestie C, Etiennot M, et al. The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research. Mol Cancer. 2024;23:166 pubmed publisher |
Domingo J, Battistini F, Cordobilla B, Zaragoz xe1 M, Sanmartin Senta xf1 es R, Alegre Martín J, et al. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study. J Transl Med. 2024;22:343 pubmed publisher |
Sorenson C, Gurel Z, Song Y, Peterson K, Blodi B, Sheibani N. Thrombospondin-1, BIM and CFH polymorphisms and response to anti-VEGF treatment in neovascular age- related macular degeneration patients. PLoS ONE. 2024;19:e0297135 pubmed publisher |
Duggins Warf M, Ghalali A, Sesen J, Martinez T, Fehnel K, Pineda S, et al. Disease specific urinary biomarkers in the central nervous system. Sci Rep. 2023;13:19244 pubmed publisher |
Krishna S, Choudhury A, Keough M, Seo K, Ni L, Kakaizada S, et al. Glioblastoma remodelling of human neural circuits decreases survival. Nature. 2023;617:599-607 pubmed publisher |
Oldfield L, Evans A, Rao R, Jenkinson C, Purewal T, Psarelli E, et al. Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. EBioMedicine. 2022;75:103802 pubmed publisher |
Fernández Simón E, Lleixà C, Suarez Calvet X, Diaz Manera J, Illa I, Gallardo E, et al. Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes. BMC Musculoskelet Disord. 2020;21:784 pubmed publisher |
Alehagen U, Shamoun L, Wågsäter D. Increased cardiovascular mortality in females with the a/a genotype of the SNPs rs1478604 and rs2228262 of thrombospondin-1. BMC Med Genet. 2020;21:179 pubmed publisher |
Mussbacher M, Krammer T, Heber S, Schrottmaier W, Zeibig S, Holthoff H, et al. Impact of Anticoagulation and Sample Processing on the Quantification of Human Blood-Derived microRNA Signatures. Cells. 2020;9: pubmed publisher |
Polster S, Sharma A, Tanes C, Tang A, Mericko P, Cao Y, et al. Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun. 2020;11:2659 pubmed publisher |
Yagi H, Nishigori M, Murakami Y, Osaki T, Muto S, Iba Y, et al. Discovery of novel biomarkers for atherosclerotic aortic aneurysm through proteomics-based assessment of disease progression. Sci Rep. 2020;10:6429 pubmed publisher |
Lie S, Vieira B, Arruda S, Simões M, Ashander L, Furtado J, et al. Molecular Basis of The Retinal Pigment Epithelial Changes That Characterize The Ocular Lesion in Toxoplasmosis. Microorganisms. 2019;7: pubmed publisher |
Joo Y, Jang J, Lee S, Yoo S, Kwon J, Nam S, et al. Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression. Sci Rep. 2019;9:9137 pubmed publisher |
Daubon T, Léon C, Clarke K, Andrique L, Salabert L, Darbo E, et al. Deciphering the complex role of thrombospondin-1 in glioblastoma development. Nat Commun. 2019;10:1146 pubmed publisher |
Haegele S, Fuxsteiner J, Pereyra D, Koeditz C, Rumpf B, Schuetz C, et al. Elevated ADAMTS13 Activity is Associated with Poor Postoperative Outcome in Patients Undergoing Liver Resection. Sci Rep. 2018;8:16823 pubmed publisher |
Watt K, Newsted D, Voorand E, Gooding R, Majewski A, Truesdell P, et al. MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma. Cell Signal. 2018;50:25-36 pubmed publisher |
Yang S, Song R, Li X, Zhang T, Fu J, Cui X. Thrombospondin-2 predicts response to treatment with intravenous immunoglobulin in children with Kawasaki disease. BMJ Paediatr Open. 2018;2:e000190 pubmed publisher |
Mussbacher M, Schrottmaier W, Salzmann M, Brostjan C, Schmid J, Starlinger P, et al. Optimized plasma preparation is essential to monitor platelet-stored molecules in humans. PLoS ONE. 2017;12:e0188921 pubmed publisher |
Muramatsu D, Okabe M, Takaoka A, Kida H, Iwai A. Aureobasidium pullulans produced β-glucan is effective to enhance Kurosengoku soybean extract induced Thrombospondin-1 expression. Sci Rep. 2017;7:2831 pubmed publisher |
Amarasekera A, Assadi Khansari B, Liu S, Black M, Dymmott G, Rogers N, et al. Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adults. PLoS ONE. 2017;12:e0174435 pubmed publisher |
Chandran S, Watkins J, Abdul Aziz A, Shafat M, Calvert P, Bowles K, et al. Inflammatory Differences in Plaque Erosion and Rupture in Patients With ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc. 2017;6: pubmed publisher |
Di Mauro C, Rosa R, D Amato V, Ciciola P, Servetto A, Marciano R, et al. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers. Br J Cancer. 2017;116:1425-1435 pubmed publisher |
Miao X, Zhang W, Huang Z, Li N. Unaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet Hyperreactivity. PLoS ONE. 2016;11:e0162405 pubmed publisher |
Verstraete M, Debucquoy A, Dekervel J, Van Pelt J, Verslype C, Devos E, et al. Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial. Br J Cancer. 2015;112:1314-25 pubmed publisher |
Gokyu M, Kobayashi H, Nanbara H, Sudo T, Ikeda Y, Suda T, et al. Thrombospondin-1 production is enhanced by Porphyromonas gingivalis lipopolysaccharide in THP-1 cells. PLoS ONE. 2014;9:e115107 pubmed publisher |
Yao L, Dong H, Luo Y, Du J, Hu W. Net platelet angiogenic activity (NPAA) correlates with progression and prognosis of non-small cell lung cancer. PLoS ONE. 2014;9:e96206 pubmed publisher |
Armstrong A, Haggman M, Stadler W, Gingrich J, Assikis V, Polikoff J, et al. Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer. Clin Cancer Res. 2013;19:6891-901 pubmed publisher |
Tsuchida R, Osawa T, Wang F, Nishii R, Das B, Tsuchida S, et al. BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors. Oncogene. 2014;33:3803-11 pubmed publisher |
Goretti E, Rolland Turner M, Léonard F, Zhang L, Wagner D, Devaux Y. MicroRNA-16 affects key functions of human endothelial progenitor cells. J Leukoc Biol. 2013;93:645-55 pubmed publisher |
Lindner D, Wu Y, Haney R, Jacobs B, Fruehauf J, Tuthill R, et al. Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis. Matrix Biol. 2013;32:123-32 pubmed publisher |
Lee S, Ghosh S, Han H, Stone R, Bottsford Miller J, Shen D, et al. Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma. Clin Cancer Res. 2012;18:4114-21 pubmed publisher |
Niccoli G, Giubilato S, Leo A, Cosentino N, Fracassi F, Cataneo L, et al. Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy. Thromb Haemost. 2012;108:133-9 pubmed publisher |
Firlej V, Mathieu J, Gilbert C, Lemonnier L, Nakhlé J, Gallou Kabani C, et al. Thrombospondin-1 triggers cell migration and development of advanced prostate tumors. Cancer Res. 2011;71:7649-58 pubmed publisher |
Loupakis F, Cremolini C, Fioravanti A, Orlandi P, Salvatore L, Masi G, et al. Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer. Br J Cancer. 2011;104:1262-9 pubmed publisher |
Vázquez López M, Llamas M, Galera R, Sanchez A, Lendinez F, Gonzalez Ripoll M, et al. Comparison between one and three doses a week of recombinant erythropoietin in very low birth weight infants. J Perinatol. 2011;31:118-24 pubmed publisher |
Mittal R, Gonzalez Gomez I, Prasadarao N. Escherichia coli K1 promotes the ligation of CD47 with thrombospondin-1 to prevent the maturation of dendritic cells in the pathogenesis of neonatal meningitis. J Immunol. 2010;185:2998-3006 pubmed publisher |
Ding W, Knox T, Tschumper R, Wu W, Schwager S, Boysen J, et al. Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch. Blood. 2010;116:2984-93 pubmed publisher |
Starlinger P, Moll H, Assinger A, Nemeth C, Hoetzenecker K, Gruenberger B, et al. Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. J Thromb Haemost. 2010;8:1809-19 pubmed publisher |
Olsson A, Björk A, Vallon Christersson J, Isaacs J, Leanderson T. Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors. Mol Cancer. 2010;9:107 pubmed publisher |
Pitteri S, Jebailey L, Faca V, Thorpe J, Silva M, Ireton R, et al. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE. 2009;4:e7916 pubmed publisher |
Hyder S, Liang Y, Wu J. Estrogen regulation of thrombospondin-1 in human breast cancer cells. Int J Cancer. 2009;125:1045-53 pubmed publisher |
Oh J, Kim M, Shin M, Wee W, Lee J. Cytokine secretion by human mesenchymal stem cells cocultured with damaged corneal epithelial cells. Cytokine. 2009;46:100-3 pubmed publisher |
